Emerald Advisers, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Emerald Advisers, LLC

$2.41 Billion
Q3 2024

A detailed history of Emerald Advisers, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Emerald Advisers, LLC holds 569,798 shares of RARE stock, worth $25.2 Million. This represents 1.32% of its overall portfolio holdings.

Number of Shares

569,798

Previous 486,682 17.08%

Holding current value

$25.2 Million

Previous $20 Million 58.24%

% of portfolio

1.32%

Previous 0.9%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$40.21 - $59.36 $3.34 Million - $4.93 Million	83,116 Added 17.08%	569,798 $31.7 Million
Q2 2024 Aug 06, 2024	SELL	$37.42 - $51.61 $54,483 - $75,144	-1,456 Reduced 0.3%	486,682 $20 Million
Q1 2024 May 08, 2024	BUY	$43.02 - $53.69 $258,120 - $322,140	6,000 Added 1.24%	488,138 $22.8 Million
Q4 2023 Feb 05, 2024	SELL	$31.73 - $49.19 $303,053 - $469,813	-9,551 Reduced 1.94%	482,138 $23.1 Million
Q3 2023 Oct 26, 2023	SELL	$34.92 - $46.66 $2.11 Million - $2.82 Million	-60,447 Reduced 10.95%	491,689 $17.5 Million
Q2 2023 Jul 25, 2023	BUY	$37.35 - $52.15 $2.31 Million - $3.23 Million	61,975 Added 12.64%	552,136 $25.5 Million
Q1 2023 May 04, 2023	BUY	$36.99 - $48.71 $5.38 Million - $7.08 Million	145,436 Added 42.19%	490,161 $19.7 Million
Q4 2022 Feb 03, 2023	SELL	$33.72 - $46.33 $79,444 - $109,153	-2,356 Reduced 0.68%	344,725 $16 Million
Q3 2022 Oct 25, 2022	BUY	$39.96 - $66.14 $5.83 Million - $9.65 Million	145,864 Added 72.49%	347,081 $14.4 Million
Q2 2022 Jul 29, 2022	SELL	$45.8 - $85.4 $1.04 Million - $1.94 Million	-22,735 Reduced 10.15%	201,217 $12 Million
Q1 2022 Apr 29, 2022	SELL	$62.2 - $84.4 $733,524 - $995,329	-11,793 Reduced 5.0%	223,952 $16.3 Million
Q4 2021 Feb 02, 2022	BUY	$73.71 - $87.86 $2.92 Million - $3.48 Million	39,621 Added 20.2%	235,745 $19.8 Million
Q3 2021 Oct 28, 2021	SELL	$77.92 - $102.4 $1.1 Million - $1.45 Million	-14,119 Reduced 6.72%	196,124 $17.7 Million
Q2 2021 Jul 29, 2021	SELL	$92.19 - $115.71 $1.67 Million - $2.1 Million	-18,125 Reduced 7.94%	210,243 $20 Million
Q1 2021 Apr 29, 2021	BUY	$106.9 - $167.73 $159,601 - $250,420	1,493 Added 0.66%	228,368 $26 Million
Q4 2020 Jan 29, 2021	BUY	$84.4 - $177.39 $19.1 Million - $40.2 Million	226,875 New	226,875 $31.4 Million

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.6M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.1B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Account

Emerald Advisers, LLC Ultragenyx Pharmaceutical Inc. Transaction History